Literature DB >> 27992244

Averaging Trials Versus Averaging Trial Peaks: Impact on Study Outcomes.

Kevin D Dames1, Jeremy D Smith2, Gary D Heise2.   

Abstract

Gait data are commonly presented as an average of many trials or as an average across participants. Discrete data points (eg, maxima or minima) are identified and used as dependent variables in subsequent statistical analyses. However, the approach used for obtaining average data from multiple trials is inconsistent and unclear in the biomechanics literature. This study compared the statistical outcomes of averaging peaks from multiple trials versus identifying a single peak from an average profile. A series of paired-samples t tests were used to determine whether there were differences in average dependent variables from these 2 methods. Identifying a peak value from the average profile resulted in significantly smaller magnitudes of dependent variables than when peaks from multiple trials were averaged. Disagreement between the 2 methods was due to temporal differences in trial peak locations. Sine curves generated in MATLAB confirmed this misrepresentation of trial peaks in the average profile when a phase shift was introduced. Based on these results, averaging individual trial peaks represents the actual data better than choosing a peak from an average trial profile.

Entities:  

Keywords:  average profile; gait analysis; statistical design

Mesh:

Year:  2017        PMID: 27992244     DOI: 10.1123/jab.2016-0164

Source DB:  PubMed          Journal:  J Appl Biomech        ISSN: 1065-8483            Impact factor:   1.833


  2 in total

1.  Implications of sample size and acquired number of steps to investigate running biomechanics.

Authors:  Anderson Souza Oliveira; Cristina Ioana Pirscoveanu
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

2.  Biomechanical Determinants of Performance and Injury Risk During Cutting: A Performance-Injury Conflict?

Authors:  Thomas Dos'Santos; Christopher Thomas; Alistair McBurnie; Paul Comfort; Paul A Jones
Journal:  Sports Med       Date:  2021-04-03       Impact factor: 11.136

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.